Vitamin C protects against lysophosphatidylcholine-induced expression of monocyte chemoattractant protein-1 in cultured human umbilical vein endothelial cells

Journal of the Formosan Medical Association

Volumn 102, Issue 3, 2003, Pages 151-157

  Pan, Ju Pan ^a   Cheng, Tsai Mu ^b   Chou, Shiu Chin ^a   Lai, Shiau Ting ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Ascorbic acid; Cell culture; Lysophosphatidylcholines; Monocyte chemoattractant protein 1; Protein kinase C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA;

ARTICLE; CELL CULTURE; CELL PROTECTION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; OXIDATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ASCORBIC ACID; CATTLE; CELLS, CULTURED; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; RNA, MESSENGER; UMBILICAL VEINS;

EID: 0043011425     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Nelken NA. Coughlin SR, Gordon D, et al: Monocyte chemoattractant protein-1 in human atheroscleromatous plaques. J Clin Invest 1991;88:1121-7.
2. Yu X, Dluz S, Graves DT, et al: Elevated expression of monocyte chemoattractant protein-1 by vascular smooth muscle cells in hypercholeterolemic primates. Proc Natl Acad Sci USA 1992; 89:6953-7.
3. Quinn MT, Parthasarathy S, Fong LG, et al: Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during a atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-8.
4. Kugiyama K, Kerns SA, Morrisett JD, et al: Impairment of endothelium- dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-2.
5. Cushing SD, Berliner JA, Valente AJ, et al: Minimally modified low density lipoprotein induces monocyte chemotactic protein in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;5134-8.
6. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 1985;82:3000-4.
7. Vidaver GA, Ting A, Lee JW: Evidence that lysolecithin is an important causal agent of atherosclerosis. J Theor Biol 1985; 115:27-41.
8. Liu SY, Lu X, Choy S, et al: Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc Res 1994;28:1476-81.
9. Takahara N, Kashiwagi A, Maegawa H, et al: Lysophosphatidylcholine stimulates expression and production of MCP-1 by human vascular endothelial cells. Metabolism 1996;45: 559-64.
10. Halliwell B, Gutteridge JMC: The antioxidants of extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
11. Jialal I, Grundy SM: Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597-601.
12. Esterbaucer H, Dieber-Totheneder M, Striegl G, et al: Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991;53(Suppl):314S-21.
13. Frie B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
14. Jialal I, Vega GL, Grundy SM: Physiological levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 1990;83:185-91.
15. Alexander EK, Strom K, Cotgreave IA: The uptake of ascorbic acid into human umbilical vein endothelial cells and its effect on oxidant insult. Biochem Pharmacol 1995;50:1339-46.
16. Levine GN, Frei B, Koulouris SN, et al: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996;93:1107-13.
17. Yoshimura T, Yuhki N, Moore SK, et al: Human monocyte chemo-attractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclearleukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989;244:487-93.
18. Chisolm GM, Ma GP, Irwin KC, et al: 7-Beta-hydroperoxycholest-5-en-3-beta-ol, a component of human athersclerotic lesions, is the primary cytotoxin of oxidized human low-density lipoprotein. Proc Natl Acad Sci USA 1994;9:11452-6.
19. Kume N, Gimbrone MA Jr: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907-11.
20. Nakano T, Raines EW, Abraham JA, et al: Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 1994;91:1069-73.
21. Frie B: Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative modification. Am J Clin Nutr 1991;54 (Suppl):1113S-8.
22. Cross CE, van der Vliet A, O'Neill CA et al: Oxidants, anti-oxidants and respiratory tract lining fluids. Environ Health Perpect 1994; 102:185-91.
23. Suarna C, Dean RT, May J, et al: Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995; 15:1616-24.
24. Vissers MC, Lee WG, Hampton MB: Regulation of apoptosis by vitamin C specific protection of the apoptotic machinery against exposure to chlorinated oxidants. J Biol Chem 2001; 276:46835-40.
25. Jenner AM, Ruiz JE, Dunster C et al: Vitamin C protects against hypochlorous acid-induced glutathione depletion and DNA base and protein damage in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2002;22:574-80.
26. Langlois M, Duprez D, Delanghe J, et al: Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and the severity of atherosclerosis. Circulation 2001;103:1863-8.
27. Vita JA, Keaney JF, Raby KE, et al: Low plasma ascorbic acid indepedently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 1998;31:980-6.
28. Weber C, Wolfgang E, Weber K, et al: Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-92.
29. Huang A, Vita JA, Venema RC, et al: Ascorbic acid enhances endothelial nitric oxide sythase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000;275:17399-406.
30. Gokce N, Keany JF Jr, Frei B, et al: Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999;99:3234-40.
31. Steinbrecher UP: Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochem Biophys Acta 1988;959:20-30.
32. Dhariwal KR, Hartzell WO, Levine M: Ascorbic acid and dehydroascorbic acid measurements in human plasma. Am J Clin Nutr 1991;54:712-6.
33. Collins T: Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 1993;68:499-508.
34. Gosh S, Baltimore D: Activation of in vitro NF-kB by phosphorylation of its inhibitor I kB. Nature 1990;344:678-82.
35. Kugiyama K, Ohgushi M, Sugiyama S, et al: Lysophophatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res 1992;71:1422-8.
36. Sugiyama S, Kugiyama K, Ohgushi M, et al: Lysophophatidylcholine in oxidized low density lipoprotein increases endothelial dysfunction in porcine coronary arteries. Role of protein Kinase C. Circ Res 1994;74:565-75.
37. Sugiyama S, Kugiyama K, Ogata N, et al: Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 1998; 18:568-76.
38. Bowie A, O'Neill LA: Vitamin C inhibits NF kappa B activation in endothelial cells. Biochem Soc Trans 1997;25:131S.